Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Hydration Pharmaceuticals Company Ltd (HPC)

Sydney
Currency in AUD
Disclaimer
0.02
0.00(0.00%)
Closed

HPC Income Statement

Advanced Income Statement
Period Ending:
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa10.04
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.34%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4.65
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa5.39
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.81%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa53.7%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa13.13
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-7.74
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+27.66%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-77.1%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-0.64
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-604.88%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-0.64
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa-
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa0.28
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-8.1
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-8.1
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+23.61%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-80.69%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-8.1
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-8.1
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+23.61%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-80.69%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-8.1
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.04
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.32%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-0.04
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.32%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa195.13
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa195.13
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa-7.74
* In Millions of USD (except for per share items)